Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodobacter sphaeroides Peptidyl-tRNA hydrolase (pth) CSB-YP396084RLG
CSB-EP396084RLG
CSB-BP396084RLG
CSB-MP396084RLG
CSB-EP396084RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Pyrroloquinoline-quinone synthase (pqqC) CSB-YP396085RLG
CSB-EP396085RLG
CSB-BP396085RLG
CSB-MP396085RLG
CSB-EP396085RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Protein TolB (tolB) CSB-YP396086RLG
CSB-EP396086RLG
CSB-BP396086RLG
CSB-MP396086RLG
CSB-EP396086RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Translation initiation factor IF-1 (infA) CSB-YP396087RLG
CSB-EP396087RLG
CSB-BP396087RLG
CSB-MP396087RLG
CSB-EP396087RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides GTP cyclohydrolase folE2 (folE2) CSB-YP396088RLG
CSB-EP396088RLG
CSB-BP396088RLG
CSB-MP396088RLG
CSB-EP396088RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP396089RLG
CSB-EP396089RLG
CSB-BP396089RLG
CSB-MP396089RLG
CSB-EP396089RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides D-alanine--D-alanine ligase (ddl) CSB-YP396090RLG
CSB-EP396090RLG
CSB-BP396090RLG
CSB-MP396090RLG
CSB-EP396090RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Urease accessory protein UreD (ureD) CSB-YP396091RLG
CSB-EP396091RLG
CSB-BP396091RLG
CSB-MP396091RLG
CSB-EP396091RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Urease accessory protein UreF (ureF) CSB-YP396092RLG
CSB-EP396092RLG
CSB-BP396092RLG
CSB-MP396092RLG
CSB-EP396092RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (cobT) CSB-YP396093RLG
CSB-EP396093RLG
CSB-BP396093RLG
CSB-MP396093RLG
CSB-EP396093RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Deoxyguanosinetriphosphate triphosphohydrolase-like protein (Rsph17025_1197) CSB-YP396094RLG
CSB-EP396094RLG
CSB-BP396094RLG
CSB-MP396094RLG
CSB-EP396094RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Trigger factor (tig) CSB-YP396095RLG
CSB-EP396095RLG
CSB-BP396095RLG
CSB-MP396095RLG
CSB-EP396095RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Phosphopantetheine adenylyltransferase (coaD) CSB-YP396096RLG
CSB-EP396096RLG
CSB-BP396096RLG
CSB-MP396096RLG
CSB-EP396096RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides UPF0061 protein Rsph17025_1901 (Rsph17025_1901) CSB-YP396097RLG
CSB-EP396097RLG
CSB-BP396097RLG
CSB-MP396097RLG
CSB-EP396097RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Integration host factor subunit alpha (ihfA) CSB-YP396098RLG
CSB-EP396098RLG
CSB-BP396098RLG
CSB-MP396098RLG
CSB-EP396098RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides NADH-quinone oxidoreductase subunit B 2 (nuoB2) CSB-YP396099RLG
CSB-EP396099RLG
CSB-BP396099RLG
CSB-MP396099RLG
CSB-EP396099RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 10 kDa chaperonin (groS) CSB-YP396100RLG
CSB-EP396100RLG
CSB-BP396100RLG
CSB-MP396100RLG
CSB-EP396100RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides UPF0173 metal-dependent hydrolase Rsph17025_2229 (Rsph17025_2229) CSB-YP396101RLG
CSB-EP396101RLG
CSB-BP396101RLG
CSB-MP396101RLG
CSB-EP396101RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Protein RecA (recA) CSB-YP396102RLG
CSB-EP396102RLG
CSB-BP396102RLG
CSB-MP396102RLG
CSB-EP396102RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 50S ribosomal protein L15 (rplO) CSB-YP396103RLG
CSB-EP396103RLG
CSB-BP396103RLG
CSB-MP396103RLG
CSB-EP396103RLG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>